Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00319072 · ClinicalTrials.gov registry record · Phase 2

Hormone Replacement Therapy (HRT) Website Tool

A Phase 2 study, sponsored by National Institute on Aging (NIA).

Completed
Registry status
Phase 2
Development phase
280
Enrollment target

NCT00319072 is a Phase 2 study that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 280 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00319072, a Phase 2 study, has completed, sponsored by National Institute on Aging (NIA).

COMPLETED
Registry status
Phase 2
Development phase
280 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate a prototype web-based module for patients to generate appropriate and focused health information along with a customized set of questions to take to their health care provider for discussion on hormone replacement therapy.

Interventions

  • BEHAVIORAL TalkToYourDoc(sm) hormone therapy module

Trial Details

FieldValue
Enrollment Target 280 participants
Start Date 2004-03
Est. Completion 2005-12
Phase Phase 2

Sponsor

National Institute on Aging (NIA)

131 total trials

What the Registry Record Tells You About NCT00319072

The ClinicalTrials.gov registry entry for NCT00319072 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which TalkToYourDoc(sm) hormone therapy module is the first listed.

NCT00319072 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00319072 about?

NCT00319072 is a clinical study titled "Hormone Replacement Therapy (HRT) Website Tool". The purpose of this study is to evaluate a prototype web-based module for patients to generate appropriate and focused health information along with a customized set of questions to take to their health care provider for discussion on hormone replacement therapy.

What is the current status of trial NCT00319072?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 280 participants. The study started on 2004-03. Estimated completion is 2005-12.

What interventions are being tested in trial NCT00319072?

The interventions under investigation include: TalkToYourDoc(sm) hormone therapy module (BEHAVIORAL).

Who is sponsoring clinical trial NCT00319072?

This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.